DA Ahlquist, HS Wieand, CG Moertel, DB McGill, CL … - Jama, 1993 - Am Med Assoc OBJECTIVES--To define the validity of fecal blood as a marker for colorectal neoplasia in the
screening setting and to compare yields by Hemoccult and HemoQuant fecal occult blood screening
tests. DESIGN--A multicenter masked comparison of fecal blood test results against ... Cited by 296 - Related articles - BL Direct - All 6 versions
R Yip, PJ Limburg, DA Ahlquist, HA Carpenter, A O'neill … - Jama, 1997 - Am Med Assoc OBJECTIVE: To confirm prevalent iron deficiency among Yupik Eskimos living in Alaska and
to explore the frequency of and potential lesions accounting for occult gastrointestinal
bleeding. DESIGN: Descriptive survey. SETTING: Rural Arctic community. SUBJECTS: A ... Cited by 82 - Related articles - BL Direct - All 6 versions
PJ Limburg, DA Ahlquist, WJ Sandborn, … - … American journal of …, 2000 - interscience.wiley.com OBJECTIVE: Chronic diarrhea is a relatively common condition with multiple diverse
etiologies. Stool testing may serve as a diagnostic aid to discriminate the presence or absence
of organic pathology, such as colorectal inflammation. Calprotectin (a leukocyte-derived ... Cited by 70 - Related articles - BL Direct - All 6 versions
DA Ahlquist, DB McGill, JL Fleming, S … - CA A Cancer Journal … - interscience.wiley.com The assumption that asymptomatic colorectal cancers bleed provides the rationale for widespread
stool screening. The authors studied 12 patients with unoperated colorectal cancer but without
colorectal symptoms and six healthy volunteers as laboratory controls. All stools were ... Cited by 69 - Related articles - All 2 versions
A Smith, GP Young, SR Cole, P Bampton - CA A Cancer Journal for … - interscience.wiley.com It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ... Cited by 51 - Related articles - BL Direct - All 6 versions
PJ Limburg, ME Devens, JJ Harrington, NN Diehl, … - The American journal of …, 2003 - nature.com Stool testing is a well established method of screening for colorectal neoplasia. Emerging data
suggest that novel biomarkers may offer performance advantages over fecal occult blood. In
this large, prospective study, we assessed fecal calprotectin (a leukocyte-derived protein) ... Cited by 43 - Related articles - BL Direct - All 6 versions
JA Gilbert, DA Ahlquist, DW Mahoney, AR … - Scandinavian …, 1996 - informahealthcare.com JA GILBERT, DA AHLQUIST, D. W. MAHONEY, A. R. ZINSMEISTER, J. RUBIN & R. D. ELLEFSON
Divisions of Gastroenterology, Biostatistics, Medical Oncology, and Laboratory Medicine, Mayo
Clinic, Rochester, Minnesota, USA ... Gilbert JA, Ahlquist DA, Mahoney DW, Zinsmeister ... Cited by 33 - Related articles - BL Direct - All 4 versions
DA Ahlquist, GG Klee, DB McGill, RD … - Archives of Internal …, 1990 - archinte.highwire.org \s=b\To assess the contribution of fecal blood testing to cancer detection in a clinical practice
setting, we studied records from 160 patients with both a new tissue diagnosis of colorectal
ade- nocarcinoma and a preceding stool blood test (HemoQuant, Mayo Medical ... Cited by 29 - Related articles - All 3 versions
[CITATION] 2 Approach to the patient with occult gastrointestinal bleeding
J Kristinsson, K Nygaard, E Aadland, S Barstad, J … - Digestion, 2000 - content.karger.com Fecal calprotectin (CPT) is elevated in the majority of patients with known colorectal cancer
(CRC), but the specificity is not clarified. Aim: To evaluate if a CPT test (PhiCal ELISA) was more
sensitive than Hemoccult II test in detecting colorectal neoplasia, and to obtain reference ... Cited by 24 - Related articles - BL Direct - All 6 versions
